What the Research Says
Omega-3 fatty acids have an extensive evidence base spanning cardiovascular, neurological, and inflammatory conditions. The landmark REDUCE-IT trial (2019, NEJM, n=8,179) demonstrated that 4g/day of pure EPA reduced major adverse cardiovascular events by 25%. For mental health, a 2019 meta-analysis by Liao et al. in Translational Psychiatry confirmed that EPA-predominant formulas significantly reduce depressive symptoms. The relationship between DHA and brain structure is well-established, with DHA comprising a significant portion of brain fatty acids and declining with age.